Details for New Drug Application (NDA): 019432

✉ Email this page to a colleague

NDA 019432 describes SPECTAMINE, which is a drug marketed by IMP and is included in one NDA. Additional details are available on the SPECTAMINE profile page.

The generic ingredient in SPECTAMINE is iofetamine hydrochloride i-123. Additional details are available on the iofetamine hydrochloride i-123 profile page.

Summary for 019432

Tradename:	SPECTAMINE
Applicant:	Imp
Ingredient:	iofetamine hydrochloride i-123
Patents:	0

Medical Subject Heading (MeSH) Categories for 019432

Radiopharmaceuticals

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	INJECTABLE;INJECTION			Strength	1mCi/ML
Approval Date:	Dec 24, 1987	TE:		RLD:	No

Expired US Patents for NDA 019432

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Imp	SPECTAMINE	iofetamine hydrochloride i-123	INJECTABLE;INJECTION	019432-001	Dec 24, 1987	⤷ Subscribe	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.